C3 Jian Adds Two Top Oral Healthcare Professionals to Its Board of Directors
November 10, 2014 06:00 ET
|
C3 Jian, Inc.
LOS ANGELES, Nov. 10, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare through new pharmaceutical products, announced the appointment of Steven...
C3 Jian Completes Phase 2 Clinical Trial of Anti-Cavity Drug
September 09, 2014 06:00 ET
|
C3 Jian, Inc.
LOS ANGELES, Sept. 9, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that it has successfully completed the initial Phase 2...
C3 Jian Initiates Phase 2 Clinical Trial of Anti-Cavity Drug
March 07, 2014 18:40 ET
|
C3 Jian, Inc.
LOS ANGELES, March 7, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that the first Phase 2 Clinical Trial for its novel drug,...
C3 Jian Completes C16G2 Phase 1 Clinical Study Enrollment
February 19, 2013 14:50 ET
|
C3 Jian, Inc.
LOS ANGELES, Feb. 19, 2013 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced the successful completion of Phase 1 study enrollment for its...
C3 Jian Appoints Richard Bastiani to Board of Directors
October 04, 2012 17:19 ET
|
C3 Jian, Inc.
LOS ANGELES, Oct. 4, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced the appointment of Richard Bastiani, Ph.D., as a member of its...